Liminatus Pharma Inc. (LIMN) vs Orgenesis Inc. (ORGS)
Liminatus Pharma Inc. and Orgenesis Inc. are both Biotechnology companies. Liminatus Pharma Inc. and Orgenesis Inc. are of similar size ($5.7M and $5.6M). Liminatus Pharma Inc. has the higher net margin (0.00% vs −4,653.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Liminatus Pharma Inc. leads on 8 and Orgenesis Inc. on 3.
Valuation
Profitability
| Metric | LIMN | ORGS | Biotechnology median |
|---|---|---|---|
| Gross margin | — | (86.28%) | 65.16% |
| Operating margin | 0.00% | (3,842.32%) | 0.00% |
| Net margin | 0.00% | (4,653.62%) | 0.00% |
| Free cash flow margin | 0.00% | (1,675.27%) | 0.00% |
| Return on equity | 294.43% | 164.62% | (57.72%) |
| Return on assets | (471.47%) | (605.73%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack